U.S. Auto Stock News

Redwire recently secured a contract to supply docking systems for The Exploration Company’s Nyx spacecraft and announced additional agreements aimed at expanding its space infrastructure business across Europe. This combination of high-profile spacecraft work and deeper European exposure highlights how Redwire is embedding its technology in emerging commercial space platforms. We’ll now examine how the Nyx docking systems win and broader European expansion influence Redwire’s existing...

TOMS Capital’s disclosed investment in Target (TGT) has turned fresh attention to the retailer’s sales slump, leadership transition and operational reset, and has raised questions about how activist pressure could influence the company’s next moves. See our latest analysis for Target. At around $100.51, Target’s recent 1 month share price return of 9.02% and 3 month share price return of 12.59% suggest momentum has picked up again. However, the 1 year total shareholder return of 24.66% and 3...

Alamo Group Inc. recently announced that its Board of Directors approved a quarterly dividend of US$0.34 per share, increasing the payout by US$0.04, payable on January 29, 2026 to shareholders of record as of January 16, 2026. This more than 13% dividend increase underlines management’s emphasis on consistent cash returns to shareholders within its broader capital allocation framework. Next, we’ll examine how Alamo Group’s higher recurring dividend payout interacts with its existing...

In recent months, Clorox has been rebuilding efficiency and normalizing costs after earlier disruptions, while analysts have generally taken a more cautious stance ahead of its upcoming fiscal Q2 2026 earnings release. At the same time, investor interest in defensive consumer staples and Clorox’s emphasis on health, wellness, and professional cleaning solutions have supported a healthier gross margin profile and renewed attention to its longer-term earnings stability. Now we’ll examine how...

What recent performance tells you about Newell Brands Newell Brands (NWL) has drawn investor attention after a prolonged share price slump, including a 61% total return decline over the past year and a 71% decline over the past 3 years. With the stock recently closing at $3.72 and annual revenue of $7.256b against a net income loss of $24 million, many investors are reassessing how the business fundamentals line up with the current valuation. See our latest analysis for Newell Brands. That...

Enterprise Products Partners (EPD) is back in focus after recent unit price moves, with the units showing mixed short term performance while sitting on a 1 year total return of 7.8% for investors. See our latest analysis for Enterprise Products Partners. The latest share price of $32.16 comes after mixed recent moves, with a 7 day share price return of 0.75% and a 30 day share price return decline of 1.38%. The 1 year total shareholder return of 7.83% and 5 year total shareholder return of...

Omeros (OMER) drew fresh investor attention after the U.S. Food and Drug Administration approved YARTEMLEA for hematopoietic stem cell transplant associated thrombotic microangiopathy, and the company is preparing a U.S. launch and related reimbursement infrastructure. See our latest analysis for Omeros. The FDA approval appears to be the main backdrop for recent price action, with a 30 day share price return of 50.97% and a 90 day share price return of 268.92%. Meanwhile, the 1 year total...

Casella Waste Systems (CWST) shareholders are watching a rare leadership transition, as Edmond R. “Ned” Coletta steps in as Chief Executive Officer and joins the Board, becoming only the company’s second CEO. See our latest analysis for Casella Waste Systems. At a share price of $98.65, Casella Waste Systems has seen a 7.34% 90 day share price return, while the 1 year total shareholder return of a 6.85% decline contrasts with a 24.37% gain over three years. This suggests longer term momentum...

Viking Therapeutics (VKTX) has drawn fresh attention after recent trading left the stock at a last close of $35.42, with performance mixed between short term pressure and stronger gains over the past 3 months. See our latest analysis for Viking Therapeutics. Looking beyond the latest move, Viking Therapeutics shows mixed momentum, with a 1 day share price return of 0.68% set against a 30 day share price return of an 8.12% decline and a 1 year total shareholder return of a 16.72% loss. The 3...

Atlantic Union Bankshares (AUB) shares moved higher after quarterly earnings showed revenue growth and earnings per share in line with expectations, even as net interest income fell short and sector conditions influenced investor sentiment. See our latest analysis for Atlantic Union Bankshares. The recent post earnings move, with the share price at US$35.52, comes after a mixed few months where the 30 day share price return of 3.29% contrasts with a slightly negative 90 day move. At the same...

In recent days, The PNC Financial Services Group, Inc. declared cash dividends across several preferred share series and affirmed a US$1.70 quarterly common dividend, with payment dates ranging from February 5 to March 15, 2026, for shareholders of record on the respective January and February record dates. At the same time, PNC’s earlier appointment of former BlackRock executive Mark Wiedman as president has sharpened attention on how leadership changes and capital return policies may...

Klarna Group (NYSE:KLAR) is under pressure after multiple law firms launched securities class action lawsuits tied to its September 2025 IPO. The suits focus on alleged disclosure issues around loss reserves on its buy now, pay later loans. See our latest analysis for Klarna Group. The legal headlines arrive after a weak run for the stock, with a 30.9% decline in the 90 day share price return and an 8.8% decline in the 1 month share price return, suggesting momentum has been fading even...

Rezdiffra revenue momentum and competitive pressures Madrigal Pharmaceuticals (MDGL) is in focus after reporting Rezdiffra revenue annualizing above US$1b, while remaining loss-making and facing growing competition from GLP-1 drugs and emerging FGF21 inhibitors in the MASH market. See our latest analysis for Madrigal Pharmaceuticals. The strong Rezdiffra update comes after a 36.12% 90 day share price return to US$593.87 and a very large 5 year total shareholder return of 414.08%, suggesting...

Suburban Propane Partners, L.P. recently completed a private offering of US$350 million in 6.500% senior notes due 2035, using the roughly US$344.3 million in net proceeds and revolving credit facility borrowings to fund the redemption of its 5.875% senior notes due 2027, which are scheduled to be fully redeemed on January 7, 2026. This refinancing shifts the partnership’s debt profile toward longer-term obligations, which could influence its interest costs, balance sheet structure, and...

Fresh attention on Chimera Investment (CIM) is being driven by renewed concern that its elevated dividend yield may be hard to sustain as interest rate swings and housing market stress weigh on its leveraged mortgage portfolio. See our latest analysis for Chimera Investment. That tension is showing up in the numbers, with a 2.49% 1 day share price return at the latest close of US$12.74 sitting against a 0.75% 1 year total shareholder return and a weaker 5 year record. This suggests momentum...

In its latest quarterly update, released prior to today, Sanmina reported revenue rising 3.9% year on year and set next-quarter EPS and revenue guidance above analyst expectations, citing sustained strength in Communications Networks and Cloud and AI Infrastructure demand. This outperformance and upbeat outlook underline how Sanmina’s exposure to data-centric infrastructure end-markets is currently reinforcing its broader electronics manufacturing business. We’ll now examine how Sanmina’s...

What Zenas BioPharma’s recent performance tells you Zenas BioPharma (ZBIO) has been on many watchlists after a sharp move in its share price over the past 3 months, even as shorter term returns over the past week and month have been negative. For context, the stock closed at US$34.50, with a 1 day return of about 5% decline, a 7 day return of roughly 11.7% decline, and a month return of about 12.4% decline, while the past 3 months show a gain above 65%. If you are looking at this recent...

In recent months, Joby Aviation has expanded its air-taxi push by partnering with Metropolis Technologies to develop up to 25 vertiports across the U.S., progressing flight testing with Toyota in Japan and advancing plans for commercial eVTOL operations in the Middle East and United States. Amid ongoing losses and uncertain certification timing, Joby’s decision to double manufacturing capacity and invest in infrastructure signals a commitment to scaling its network ahead of widespread...

The Trump administration’s decision to delay planned tariff hikes on furniture imports has eased some pressure on RH (RH), which had been dealing with higher costs and supply chain disruptions. See our latest analysis for RH. That relief has coincided with a sharp 20.09% 1 month share price return to US$193.41 and a 7.96% 1 day jump. However, the 1 year total shareholder return of 53.39% decline and 5 year total shareholder return of 60.40% decline show that longer term momentum has been...

Why Welltower is on investors’ radar today Without a single headline event setting the tone, interest in Welltower (WELL) is being driven by its role in seniors and wellness housing and how its recent share performance compares with its longer term track record. See our latest analysis for Welltower. The share price is at $186.94 after a recent 8.5% 1 month share price return decline. However, a 90 day share price return of 8.06% and a 1 year total shareholder return of 53.34% show that...

Recently, BofA Securities downgraded Omnicom Group to an “Underperform” rating, citing concerns about organic growth and the earnings impact of planned asset disposals. At the same time, Omnicom has raised its dividend and continued integrating capabilities like TPN into Flywheel, underscoring its focus on retail and commerce growth alongside larger platform and acquisition plans. Next, we’ll examine how BofA’s downgrade on organic growth concerns interacts with Omnicom’s merger-driven...

Mercury Systems (MRCY) is back in focus after its latest quarter came in ahead of analysts’ expectations, with revenue up 10.2% year on year and additional growth in backlog, adjusted EBITDA, and free cash flow. See our latest analysis for Mercury Systems. The strong quarterly beat and improved cash generation have been followed by a 4.14% 1 day share price return and a 7.72% 30 day share price return, even though the 90 day share price return is an 8.91% decline and the 5 year total...

Recent trading in MDU Resources Group (MDU) has drawn attention after the stock’s 1 day move of 1.79%, alongside a one-month return of 3.17% and a three-month total return of 9.12%. See our latest analysis for MDU Resources Group. Zooming out, the recent 3 month share price return of 9.12% sits alongside a 1 year total shareholder return of 14.34%. This hints that momentum has been building rather than fading around the current US$19.87 level. If MDU Resources Group has caught your eye, it...

Bausch Health Companies (NYSE:BHC) recently completed a refinancing that exchanges existing 2028 senior secured notes for US$1.6b of new 10.00% Senior Secured Notes due 2032. This transaction reshapes its long term debt profile for investors. See our latest analysis for Bausch Health Companies. The refinancing news comes as the share price trades at US$7.21, with a 90 day share price return of 12.83% contrasting with a 1 year total shareholder return decline of 7.56%. This suggests recent...